» Articles » PMID: 6973591

A Radioactive Antigen-binding Assay for the Measurement of Antibody to Haemophilus Influenzae Type B Capsular Polysaccharide

Overview
Publisher Elsevier
Date 1981 Jan 1
PMID 6973591
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

A new polyethylene glycol (PEG) radioimmunoprecipitation assay was developed for the detection of antibody to Haemophilus influenzae b capsular polysaccharide, polyribosylribitol phosphate (PRP). The radioactive antigen, [3H]PRP, with a high specific activity, was produced by growing the organism in the presence of [3H]ribose and was purified by hydroxylapatite and Sepharose 4B column chromatography. In the assay, PEG (12.5%) was used to separate antibody-bound [3H]PRP from free [3H]PRP. The assay covered the range of 0.5 and 20 ng antibody/assay at a maximum sensitivity of 0.5 approximately 1.0 ng antibody/assay. With various dilutions (1-20 ng antibody/assay) of S. Klein reference antiserum, the within-run coefficient of variation (CV) of 10 replicates ranged from 3.5 to 8.5%. Average CVs of 8.9% and 11.0% were obtained in the between-run and day-to-day reproducibility studies. The binding of [3H]PRP to S. Klein reference antiserum was severely inhibited by a minute amount of non-radioactive PRP; however, no significant interference was found in the presence of high concentrations of polysaccharides from Escherichia coli K100 and Streptococcus pneumoniae indicating that the RIA was highly specific for antibody to H. influenzae b PRP. The present RIA is a simple, specific, sensitive and reproducible procedure for the evaluation of antibody responses of young animals and infants to H. influenzae b vaccines and infections.

Citing Articles

Immunogenicity and Reactogenicity following Primary Immunisation with a Combined DTaP-HBV Vaccine and a Haemophilus influenzae Type B Vaccine Administered by Separate or Mixed Injection.

Gabutti G, Bona G, Dentico P, Bamfi F, Hardt K, Majori S Clin Drug Investig. 2007; 25(5):315-23.

PMID: 17532669 DOI: 10.2165/00044011-200525050-00004.


A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b.

Mariani M, Luzzi E, Proietti D, Mancianti S, Casini D, Costantino P Clin Diagn Lab Immunol. 1998; 5(5):667-74.

PMID: 9729534 PMC: 95638. DOI: 10.1128/CDLI.5.5.667-674.1998.


Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.

Steele N, Munson Jr R, Granoff D, CUMMINS J, Levine R Infect Immun. 1984; 44(2):452-8.

PMID: 6609128 PMC: 263540. DOI: 10.1128/iai.44.2.452-458.1984.


Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia.

Shenep J, Munson Jr R, Barenkamp S, Granoff D Infect Immun. 1983; 42(1):257-63.

PMID: 6604698 PMC: 264552. DOI: 10.1128/iai.42.1.257-263.1983.


Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates.

Munson Jr R, Shenep J, Barenkamp S, Granoff D J Clin Invest. 1983; 72(2):677-84.

PMID: 6603479 PMC: 1129227. DOI: 10.1172/JCI111017.